Atypical Protein Kinase Cι as a human oncogene and therapeutic target
- 1 March 2014
- journal article
- review article
- Published by Elsevier in Biochemical Pharmacology
- Vol. 88 (1) , 1-11
Abstract
No abstract availableKeywords
This publication has 102 references indexed in Scilit:
- Oncogenic Activity of Ect2 Is Regulated through Protein Kinase Cι-mediated PhosphorylationJournal of Biological Chemistry, 2011
- Crystal Structure and Allosteric Activation of Protein Kinase C βIICell, 2011
- Protein kinase Cι expression and oncogenic signaling mechanisms in cancerJournal of Cellular Physiology, 2010
- Networking with AKAPs: Context-dependent Regulation of Anchored EnzymesMolecular Interventions, 2010
- Polarity protein alterations in carcinoma: a focus on emerging roles for polarity regulatorsCurrent Opinion in Genetics & Development, 2010
- Ect2 links the PKCι–Par6α complex to Rac1 activation and cellular transformationOncogene, 2009
- Atypical protein kinase C activity is required for extracellular matrix degradation and invasion by Src‐transformed cellsJournal of Cellular Physiology, 2009
- Matrix metalloproteinase-10 is a critical effector of protein kinase Cι-Par6α-mediated lung cancerOncogene, 2008
- Protein kinase C isozymes as therapeutic targets for treatment of human cancersAdvances in Enzyme Regulation, 2008
- Specificity and mechanism of action of some commonly used protein kinase inhibitorsBiochemical Journal, 2000